Carle Cancer Center Community Clinical Oncology Program

卡尔癌症中心社区临床肿瘤学项目

• 批准号: 8324133
• 负责人: KENDRITH Martin ROWLAND
• 金额: $ 72.82万
• 依托单位: CARLE FOUNDATION
• 依托单位国家: 美国
• 财政年份: 1990
• 资助国家: 美国
• 起止时间: 1990-06-01 至 2013-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8324133
• 关键词: Advertisements; Advocacy; Advocate; American Cancer Society; American Society of Clinical Oncology; Appointment; Award; Awareness; Cancer Center; Cancer Control; Cancer Patient; Cancer Trials Support Unit; Caring; Catchment Area; Chicago; Cities; Clinic; Clinical; Clinical Research; Clinical Trials; Communication; Communities; Community Clinical Oncology Program; Community Participation; Comprehensive Cancer Center; Country; County; Eastern Cooperative Oncology Group; Education; Electronic Mail; Enrollment; Ensure; Evaluation; Event; Foundations; Funding; Future Generations; Goals; Group Practice; Gynecologic Oncology Group; Health; Hematology; Housing; Illinois; Incidence; Indiana; Individual; Institution; Knowledge; Location; Malignant Neoplasms; Medical; Medical center; Michigan; Monitor; National Cancer Institute; National Surgical Adjuvant Breast and Bowel Project; Newsletter; Newspapers; North Central Cancer Treatment Group; Notification; Nurses; Participant; Patients; Pharmaceutical Preparations; Physicians; Prevention; Primary Care Physician; Principal Investigator; Professional-Patient Relations; Randomized; Recruitment Activity; Research; Research Personnel; Schedule; Screening procedure; Services; Surgical Specialties; Television; Therapy Clinical Trials; Time; Training; Translational Research; Travel; United States National Institutes of Health; Visit; Woman; base; cancer care; cancer prevention; cancer therapy; flexibility; follow-up; high standard; mortality; multidisciplinary; oncology; operation; patient population; prevention clinical trial; programs; quality assurance; response; success; symposium

Description (provided by applicant): In response to RFA CA-07-048, Community Clinical Oncology Program, National Cancer Institute, the Carle Cancer Center, Urbana, Illinois is applying for continued funding as a CCOP in East Central Illinois. As the largest private medical group practice in Illinois, with 334 physicians, the Carle Clinic Association has a fully developed cancer center program which has been involved in national clinical trial research since 1976. The Carle Cancer Center has been continuously funded as a CCOP since the program's inception in 1983. Joining Carle in this CCOP application as component institutions are Rush- Copley Medical Center in Aurora, Illinois, Joliet Oncology-Hematology Associates in Joliet, Illinois, and St. Anthony Memorial Health Center, in Michigan City, Indiana. The combined Carle Cancer Center CCOP provides services to cancer patients within a catchment area of 32 counties in east central Illinois and western Indiana, 10 counties south and southwest of Chicago, and 4 counties in northwestern Indiana. The primary center of operations for the CCOP is located at the Carle Cancer Center with all randomizations, administration, and quality assurance programs managed in Urbana, Illinois. The CCOP's primary research base is the North Central Cancer Treatment Group. There are also strong affiliations with the Eastern Cooperative Oncology Group and the National Surgical Adjuvant Breast and Bowel Project. Additionally, new affiliations were established with the Cancer Trials Support Unit in 2003 and with the Gynecologic Oncology Group in 2004. The Carle Cancer Center and its affiliates have dedicated clinical research professionals, nurses, and administrative staff to assist a multidisciplinary physician team in clinical trials that result in an average of 174 treatment credits and 260 cancer control/prevention credits annually. The goal of the Carle Cancer Center CCOP is to offer and facilitate a wide range of cancer treatment and prevention opportunities to individuals within their communities. The CCOP is dedicated to reducing cancer incidence and mortality through ongoing scientific research and to applying knowledge from research in ways that benefit all patient populations. The Carle Cancer Center CCOP believes that it is vital to maintain participation in cancer treatment and prevention clinical trials in order to provide the highest standard of cancer care to present patients and the best possible hope to future generations.

描述（申请人提供）： 为了响应RFA CA-07-048，国家癌症研究所社区临床肿瘤学项目，伊利诺伊州厄巴纳的卡尔癌症中心正在申请继续资助作为伊利诺伊州中东部的CCOP。作为伊利诺伊州最大的私人医疗集团，拥有334名医生，卡尔诊所协会拥有一个全面发展的癌症中心计划，自1976年以来一直参与国家临床试验研究。自1983年该计划成立以来，卡尔癌症中心一直作为CCOP获得持续资助。作为组成机构加入Carle的CCOP应用程序的是伊利诺斯州奥罗拉市的拉什-科普利医疗中心、伊利诺斯州乔利埃特的乔利埃特肿瘤血液学协会和印第安纳州密歇根市的圣安东尼纪念健康中心。合并后的卡尔癌症中心CCOP为伊利诺斯州中东部和印第安纳州西部的32个县、芝加哥南部和西南部的10个县以及印第安纳州西北部的4个县的集水区内的癌症患者提供服务。CCOP的主要操作中心位于Carle癌症中心，所有随机化、管理和质量保证项目均在伊利诺伊州厄巴纳管理。CCOP的主要研究基地是北中央癌症治疗小组。与东部肿瘤协作组和国家外科辅助乳腺和肠道项目也有很强的联系。此外，2003年与癌症试验支助股和2004年与妇科肿瘤小组建立了新的联系。Carle癌症中心及其附属机构拥有专门的临床研究专业人员，护士和行政人员，以协助多学科医生团队进行临床试验，平均每年获得174个治疗学分和260个癌症控制/预防学分。卡尔癌症中心CCOP的目标是为社区内的个人提供和促进广泛的癌症治疗和预防机会。CCOP致力于通过持续的科学研究降低癌症发病率和死亡率，并以使所有患者群体受益的方式应用研究知识。卡尔癌症中心CCOP认为，保持参与癌症治疗和预防临床试验至关重要，以便为目前的患者提供最高标准的癌症护理，并为后代提供最好的希望。